Brandon Drennen

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Rationally Designed Polypharmacology: α‐Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl‐1 and HDM2”.

Rationally Designed Polypharmacology: α‐Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl‐1 and HDM2

ChemMedChem(2020)10.1002/cmdc.202000278

N/A

0DataRank · unranked

14 citations

Brandon Drennen, Maryanna E. Lanning, Samuel Hughes, Rebecca Rothhaas, Paul T. Wilder +3 more

Scaffold hopping from indoles to indazoles yields dual MCL-1/BCL-2 inhibitors from MCL-1 selective leads

RSC Medicinal Chemistry(2022)10.1039/d2md00095d

N/A

0DataRank · unranked

16 citations

Christopher C. Goodis, Nathan G. Bowen, Wenbo Yu, Gregory E.A. Vickers, Paul T. Wilder +3 more

Augmenting the Anti‐Leukemic Activity of the BCL‐2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL‐2/HDAC1 and Dual BCL‐2/HDAC6 Inhibitors

Drug Development Research(2025)10.1002/ddr.70084

N/A

0DataRank · unranked

5 citations

Christian Eberly, Brandon Drennen, Christopher C. Goodis, Zoe Wuyts, Curt I. Civin +2 more